Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

CRDL

Cardiol Therapeutics (CRDL)

Cardiol Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CRDL
DateHeureSourceTitreSymboleSociété
26/02/202416h06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CRDLCardiol Therapeutics Inc
15/02/202419h15AllPennyStocks.comOrphan Drug Designation Sends Shares of this Dual-Listed Life Science Therapy Company SoaringNASDAQ:CRDLCardiol Therapeutics Inc
29/06/202317h45Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:CRDLCardiol Therapeutics Inc
29/03/202312h02Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:CRDLCardiol Therapeutics Inc
20/11/202209h35TipRanksCardiol Therapeutics (CRDL) Receives a Rating Update from a Top AnalystNASDAQ:CRDLCardiol Therapeutics Inc
20/11/202209h15TipRanksCanaccord Genuity Sticks to Their Buy Rating for Cardiol Therapeutics (CRDL)NASDAQ:CRDLCardiol Therapeutics Inc
20/04/202222h50Edgar (US Regulatory)Amended Annual Report (foreign Private Issuer) (40-f/a)NASDAQ:CRDLCardiol Therapeutics Inc
24/03/202211h07Edgar (US Regulatory)Annual Report (foreign Private Issuer) (40-f)NASDAQ:CRDLCardiol Therapeutics Inc
08/02/202222h35Edgar (US Regulatory)Voluntary Supplemental Material Filed Pursuant to Section 11(a) of the Securities Act of 1933 by Foreign Issuers (suppl)NASDAQ:CRDLCardiol Therapeutics Inc
08/02/202220h10Edgar (US Regulatory)Post-effective Amendment to Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10pos)NASDAQ:CRDLCardiol Therapeutics Inc
08/02/202219h53Edgar (US Regulatory)Amended Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10/a)NASDAQ:CRDLCardiol Therapeutics Inc
07/02/202222h39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CRDLCardiol Therapeutics Inc
26/01/202212h10Edgar (US Regulatory)Appointment of Agent for Service of Process and Undertaking (f-x)NASDAQ:CRDLCardiol Therapeutics Inc
26/01/202212h01Edgar (US Regulatory)Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10)NASDAQ:CRDLCardiol Therapeutics Inc
18/01/202222h23Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CRDLCardiol Therapeutics Inc
18/01/202222h14Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CRDLCardiol Therapeutics Inc
15/11/202116h42Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CRDLCardiol Therapeutics Inc
03/11/202113h36PR Newswire (Canada)Cardiol Therapeutics Announces Pricing of Public Offering of UnitsNASDAQ:CRDLCardiol Therapeutics Inc
02/11/202121h04PR Newswire (Canada)Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of UnitsNASDAQ:CRDLCardiol Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CRDL